相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
Kelechi Njoku et al.
CANCERS (2022)
Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
Quan Quan et al.
SCIENTIFIC REPORTS (2021)
Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
Aneta Cymbaluk-Ploska et al.
DIAGNOSTICS (2021)
Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma
Soichiro Kakimoto et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
The Effect of Prognostic Factors and Adjuvant Radiotherapy on Survival in Patients with High-Grade Early-Stage Endometrial Cancer: A Retrospective Clinical Study
Ercan Yilmaz et al.
MEDICAL SCIENCE MONITOR (2019)
Outcomes of intermediate-risk to high-risk stage I endometrial cancer: 10-year clinical experiences of using in-house multi-channel applicators in a single center
Xiao-Rong Hou et al.
CHINESE MEDICAL JOURNAL (2019)
The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome
Yu-Jung Lin et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2019)
Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis
Jinping Li et al.
CLINICA CHIMICA ACTA (2019)
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers
Roberto Angioli et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Discovery of biomarkers for endometrial cancer: current status and prospects
Tea Lanisnik Rizner
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer
Eva Myriokefalitaki et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
Tao Jiang et al.
BMC CANCER (2015)
A critical review on HE4 performance in endometrial cancer: where are we now?
Roberto Angioli et al.
TUMOR BIOLOGY (2014)
Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer
Angel Chao et al.
GYNECOLOGIC ONCOLOGY (2013)
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
Laura Zanotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer
Yu-Li Chen et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2011)
Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer
Seung-Su Han et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2010)
Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center study
Hee Seung Kim et al.
GYNECOLOGIC ONCOLOGY (2010)
Preoperative CA 125 Tumour Marker in Endometrial Cancer: Correlation With Advanced Stage Disease
Alexandra Sebastianelli et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2010)
Biologic markers in endometrial cancer treatment
Ingeborg B. Engelsen et al.
APMIS (2009)
分享论文
